Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: Impact on adjuvant therapy

C. L. Creutzberg; A. Leon-Castillo; S. M. de Boer; M. E. Powell; L. R. Mileshkin; H. J. Mackay; A. Leary; H. W. Nijman; N. Singh; P. Pollock; A. Fyles; C. Haie-Meder; V. T. H. B. M. Smit; R. J. Edmondson; H. Putter; H. C. Kitchener; E. J. Crosbie; M. de Bruyn; R. Nout; T. Bosse

Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: Impact on adjuvant therapy

C. L. Creutzberg, A. Leon-Castillo, S. M. de Boer, M. E. Powell, L. R. Mileshkin, H. J. Mackay, A. Leary, H. W. Nijman, N. Singh, P. Pollock, A. Fyles, C. Haie-Meder, V. T. H. B. M. Smit, R. J. Edmondson, H. Putter, H. C. Kitchener, E. J. Crosbie, M. de Bruyn, R. Nout, T. Bosse

Translational Immunology Groningen (TRIGR)

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	899-900
Number of pages	2
Journal	Annals of Oncology
Volume	30
Publication status	Published - Oct-2019
Event	44th Congress of the European-Society-for-Medical-Oncology (ESMO) - Barcelona, Spain Duration: 27-Sept-2019 → 1-Oct-2019

Handle.net

Persistent link

Cite this

Creutzberg, C. L., Leon-Castillo, A., de Boer, S. M., Powell, M. E., Mileshkin, L. R., Mackay, H. J., Leary, A., Nijman, H. W., Singh, N., Pollock, P., Fyles, A., Haie-Meder, C., Smit, V. T. H. B. M., Edmondson, R. J., Putter, H., Kitchener, H. C., Crosbie, E. J., de Bruyn, M., Nout, R., & Bosse, T. (2019). Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: Impact on adjuvant therapy. Annals of Oncology, 30, 899-900.

@article{23a89c6600204f709213292d1559e8eb,

title = "Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: Impact on adjuvant therapy",

author = "Creutzberg, {C. L.} and A. Leon-Castillo and {de Boer}, {S. M.} and Powell, {M. E.} and Mileshkin, {L. R.} and Mackay, {H. J.} and A. Leary and Nijman, {H. W.} and N. Singh and P. Pollock and A. Fyles and C. Haie-Meder and Smit, {V. T. H. B. M.} and Edmondson, {R. J.} and H. Putter and Kitchener, {H. C.} and Crosbie, {E. J.} and {de Bruyn}, M. and R. Nout and T. Bosse",

year = "2019",

month = oct,

language = "English",

volume = "30",

pages = "899--900",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

note = "44th Congress of the European-Society-for-Medical-Oncology (ESMO) ; Conference date: 27-09-2019 Through 01-10-2019",

}

Creutzberg, CL, Leon-Castillo, A, de Boer, SM, Powell, ME, Mileshkin, LR, Mackay, HJ, Leary, A, Nijman, HW , Singh, N, Pollock, P, Fyles, A, Haie-Meder, C, Smit, VTHBM, Edmondson, RJ, Putter, H, Kitchener, HC, Crosbie, EJ, de Bruyn, M, Nout, R & Bosse, T 2019, 'Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: Impact on adjuvant therapy', Annals of Oncology, vol. 30, pp. 899-900.

TY - JOUR

T1 - Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer

T2 - 44th Congress of the European-Society-for-Medical-Oncology (ESMO)

AU - Creutzberg, C. L.

AU - Leon-Castillo, A.

AU - de Boer, S. M.

AU - Powell, M. E.

AU - Mileshkin, L. R.

AU - Mackay, H. J.

AU - Leary, A.

AU - Nijman, H. W.

AU - Singh, N.

AU - Pollock, P.

AU - Fyles, A.

AU - Haie-Meder, C.

AU - Smit, V. T. H. B. M.

AU - Edmondson, R. J.

AU - Putter, H.

AU - Kitchener, H. C.

AU - Crosbie, E. J.

AU - de Bruyn, M.

AU - Nout, R.

AU - Bosse, T.

PY - 2019/10

Y1 - 2019/10

M3 - Meeting Abstract

SN - 0923-7534

VL - 30

SP - 899

EP - 900

JO - Annals of Oncology

JF - Annals of Oncology

Y2 - 27 September 2019 through 1 October 2019

ER -